Lista de obras - X Ampudia - Dominio Público Uruguay

35th Annual Meeting of the European Association for the Study of Diabetes

artículo científico

35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999

article

A case of lipoatrophy with insulin glargine: long-acting insulin analogs are not exempt from this complication

artículo científico publicado en 2005

A cross-sectional survey among patients and prescribers on insulin dosing irregularities and impact of mild (self-treated) hypoglycemia episodes in Spanish patients with type 2 diabetes as compared to other European patients.

artículo científico publicado en 2014

A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications?

scientific article published on 01 March 2003

Adrenocortical scintigraphy with 131I-6-beta-iodomethyl-norcholesterol (NP 59) in bilateral adrenocortical carcinoma

scientific article published on 01 June 1998

Basal Plus Basal–Bolus Approach in Type 2 Diabetes ⬇️

artículo científico publicado el 1 de junio de 2011

Biosimilars and Novel Insulins

artículo científico publicado en 2020

Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia.

artículo científico publicado en 2005

Cardiovascular disease in diabetes mellitus

artículo científico publicado en 2002

Clinical Approach to Flash Glucose Monitoring: An Expert Recommendation

scientific article published on 12 May 2019

Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.

artículo científico publicado en 2017

Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain

artículo científico publicado en 2018

Dapagliflozin, the first SGLT-2 inhibitor in the treatment of type 2 diabetes

artículo científico publicado en 2013

Diabetes screening by telecentric digital holographic microscopy.

artículo científico publicado en 2015

Efficacy and safety of adding sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline BMI ≥27 kg/m<sup>2</sup>

artículo científico publicado en 2020

Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus.

artículo científico publicado en 2016

Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.

artículo científico publicado en 2012

Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance

artículo científico publicado en 2017

Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?

artículo científico publicado en 2017

Four week administration of an ACE inhibitor and a cardioselective beta-blocker in healthy volunteers: no influence on insulin sensitivity

artículo científico publicado en 1995

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).

artículo científico publicado en 2017

Hodgkin's disease: internal mammary lymph nodes relapse diagnosed by gallium-67 scintigraphy

artículo científico publicado en 1999

Importance of daily glycemic variability in achieving glycemic targets in type 2 diabetes: role of DPP-4 inhibitors

artículo científico publicado en 2010

Interchangeability among reference insulin analogues and their biosimilars: regulatory framework, study design and clinical implications.

artículo científico publicado en 2016

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors

artículo científico publicado en 2019

Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.

artículo científico publicado en 2006

Maternal glucose tolerance status influences the risk of macrosomia in male but not in female fetuses.

artículo científico publicado en 2008

Old and new basal insulin formulations: understanding pharmacodynamics is still relevant in clinical practice

artículo científico

Plasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose Concentration

artículo científico publicado en 2018

Potential impact of American Diabetes Association (2000) criteria for diagnosis of gestational diabetes mellitus in Spain

artículo científico publicado en 2005

Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin

scientific article published on 01 July 1996

Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes

scientific article published on 13 August 2018

Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus.

artículo científico publicado en 2010

Real World Evidence of the Effectiveness on Glycaemic Control of Early Simultaneous vs Later Sequential Initiation of Basal Insulin and GLP-1 Receptor Agonists

artículo científico publicado en 2020

Real-time estimation of plasma insulin concentration from continuous glucose monitor measurements.

artículo científico publicado en 2015

Reimbursement for continuous glucose monitoring: a European view.

artículo científico publicado en 2012

Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009-2014.

artículo científico publicado en 2017

Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review

artículo científico publicado en 2013

Taspoglutide, a once‐weekly glucagon‐like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open‐label randomized trial ⬇️

artículo científico publicado el 1 de enero de 2013

Time-action profiles of the intermediate-acting insulin analogue des(64,65)-human proinsulin

artículo científico publicado en 1995

Update on postprandial hyperglycaemia: the pathophysiology, prevalence, consequences and implications of treating diabetes

scientific article published on 07 December 2018

Urinary glycosaminoglycans in active Graves ophthalmopathy

artículo científico publicado en 1992

Validation in daily clinical situations of Diascope®, a software developed to help healthcare professionals individualize antidiabetic treatment in type 2 diabetes

artículo científico publicado en 2017

ZODIAC: Consensus on herpes zoster prevention in persons with diabetes mellitus

artículo científico publicado en 2016

[Acute rifampicin-induced adrenal insufficiency]

artículo científico publicado en 1997

[Bartter's syndrome: variability and clinical course]

scientific article published on 01 January 1993

[Factors associated with amputation in diabetic patients with foot ulcer]

scientific article published on 01 February 2001

[Psoas abscess secondary to lumbar spondylodiscitis caused by gram negative bacilli]

scientific article published on 01 August 1998

[Selective therapeutic embolization in malignant insulinoma]

artículo científico publicado en 2000

[Thyroid lymphoma: a clinico-pathological study]

artículo científico publicado en 1992

[Thyroid ophthalmopathy: clinical and tomographic study]

scientific article published on 01 March 1993

Futuro de las glitazonas ⬇️

artículo científico publicado el 27 de marzo de 2011

Lista de obras de X Ampudia

35th Annual Meeting of the European Association for the Study of Diabetes

35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999

A case of lipoatrophy with insulin glargine: long-acting insulin analogs are not exempt from this complication

A cross-sectional survey among patients and prescribers on insulin dosing irregularities and impact of mild (self-treated) hypoglycemia episodes in Spanish patients with type 2 diabetes as compared to other European patients.

A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications?

Adrenocortical scintigraphy with 131I-6-beta-iodomethyl-norcholesterol (NP 59) in bilateral adrenocortical carcinoma

Basal Plus Basal–Bolus Approach in Type 2 Diabetes ⬇️

Biosimilars and Novel Insulins

Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia.

Cardiovascular disease in diabetes mellitus

Clinical Approach to Flash Glucose Monitoring: An Expert Recommendation

Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.

Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain

Dapagliflozin, the first SGLT-2 inhibitor in the treatment of type 2 diabetes

Diabetes screening by telecentric digital holographic microscopy.

Efficacy and safety of adding sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline BMI ≥27 kg/m<sup>2</sup>

Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus.

Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.

Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance

Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?

Four week administration of an ACE inhibitor and a cardioselective beta-blocker in healthy volunteers: no influence on insulin sensitivity

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).

Hodgkin's disease: internal mammary lymph nodes relapse diagnosed by gallium-67 scintigraphy

Importance of daily glycemic variability in achieving glycemic targets in type 2 diabetes: role of DPP-4 inhibitors

Interchangeability among reference insulin analogues and their biosimilars: regulatory framework, study design and clinical implications.

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors

Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.

Maternal glucose tolerance status influences the risk of macrosomia in male but not in female fetuses.

Old and new basal insulin formulations: understanding pharmacodynamics is still relevant in clinical practice

Plasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose Concentration

Potential impact of American Diabetes Association (2000) criteria for diagnosis of gestational diabetes mellitus in Spain

Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin

Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes

Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus.

Real World Evidence of the Effectiveness on Glycaemic Control of Early Simultaneous vs Later Sequential Initiation of Basal Insulin and GLP-1 Receptor Agonists

Real-time estimation of plasma insulin concentration from continuous glucose monitor measurements.

Reimbursement for continuous glucose monitoring: a European view.

Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009-2014.

Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review

Taspoglutide, a once‐weekly glucagon‐like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open‐label randomized trial ⬇️

Time-action profiles of the intermediate-acting insulin analogue des(64,65)-human proinsulin

Update on postprandial hyperglycaemia: the pathophysiology, prevalence, consequences and implications of treating diabetes

Urinary glycosaminoglycans in active Graves ophthalmopathy

Validation in daily clinical situations of Diascope®, a software developed to help healthcare professionals individualize antidiabetic treatment in type 2 diabetes

ZODIAC: Consensus on herpes zoster prevention in persons with diabetes mellitus

[Acute rifampicin-induced adrenal insufficiency]

[Bartter's syndrome: variability and clinical course]

[Factors associated with amputation in diabetic patients with foot ulcer]

[Psoas abscess secondary to lumbar spondylodiscitis caused by gram negative bacilli]

[Selective therapeutic embolization in malignant insulinoma]

[Thyroid lymphoma: a clinico-pathological study]

[Thyroid ophthalmopathy: clinical and tomographic study]

Futuro de las glitazonas ⬇️